Rare diseases
Investigational molecules
Locations
Steinbacher Hohl 2-26, Praunheim, 60488 Frankfurt, Germany
Gastroesophageal adenocarcinoma, gastric cancer, and colorectal cancer are central areas of interest, alongside multiple biliary tract cancers and cholangiocarcinoma subtypes. The portfolio also includes hepatocellular carcinoma across intermediate, advanced, and unresectable disease settings.
Research activity also covers biomarker-defined disease groups, including FGFR2-altered and HER2-positive tumors in the upper gastrointestinal tract.
Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH runs clinical trials in conditions such as Cholangiocarcinoma, Gastrooesophageal cancer, Oesophageal adenocarcinoma, Hepatocellular carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermanyGermanyGermanyGermanyGermany
AustriaGermanyAustriaGermanyGermanyAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
